Wendy F Dicicco is Interim CFO of Akari Therapeutics Plc.
Person profile
Roles
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
EyePoint Pharmaceuticals, Inc.
9 Jan 24
3
Akari Therapeutics Plc
2 Jan 24
4
EyePoint Pharmaceuticals, Inc.
22 Jun 23
4
EyePoint Pharmaceuticals, Inc.
13 Feb 23
4
SWK Holdings Corp
4 Jan 23
4
Renovacor, Inc.
5 Dec 22
4
SWK Holdings Corp
4 Oct 22
4
SWK Holdings Corp
5 Jul 22
4
Renovacor, Inc.
21 Jun 22
3
Renovacor, Inc.
21 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 20.4 | 25,014 | 510.29 k | 25,014 |
20 Jun 23 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.5 | 13,000 | 45.50 k | 13,000 |
20 Jun 23 | EYPT EyePoint Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.26 | 26,100 | 85.09 k | 26,100 |
9 Feb 23 | EYPT EyePoint Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,000 | 0.00 | 7,400 |
9 Feb 23 | EYPT EyePoint Pharmaceuticals | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,000 | 0.00 | 0 |
30 Dec 22 | SWKH Swk | Common Stock | Grant | Acquire A | No | No | 17.64 | 779 | 13.74 k | 6,182 |
30 Dec 22 | SWKH Swk | Common Stock | Grant | Acquire A | No | No | 17.64 | 1,120 | 19.76 k | 5,403 |